{"database": "lobbying", "table": "lobbying_activities", "rows": [[2151856, "c3cc4c8d-332b-44ba-b899-743068779d75", "Q2", "ACG ADVOCACY", 2057, "WALGREEN CO.", 2018, "second_quarter", "PHA", "Competition Policy Issues.\nDrug Pricing Policy Issues.", "Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2018-07-18T17:35:59.727000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2151856"], "units": {}, "query_ms": 0.2866620197892189, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}